Results 251 to 260 of about 34,346 (291)

Energy‐Based Devices for the Treatment of Cutaneous Lesions in Patients With Lupus Erythematosus and Dermatomyositis

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background The use of energy‐based devices (EBDs) for aesthetic and dermatological conditions is increasing, but data on efficacy and safety in autoimmune connective tissue disease (CTD) patients remain limited. Objectives This study assesses EBD real‐world treatment outcomes in Korean patients with lupus erythematosus (LE) and dermatomyositis
Hae Chang Joh, Mihn‐Sook Jue, Joo Yeon Ko   +2 more
wiley   +1 more source

CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes. [PDF]

Clin Cosmet Investig Dermatol
Fournier C, Sauder MB, Claveau J, Butler MO, Hijal T, Dayeh NR, Lynde CW.   +6 more
europepmc   +1 more source

Illuminating the shadows: an insight into periorbital hyperpigmentation

Guneet Awal, Navleen Kaur, Shubham
openalex   +1 more source

Targeting Melasma: Innovations in Pigment Deposition and Photoaging in Cosmetic Dermatology

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Melasma is a chronic, relapsing hyperpigmentation disorder driven by complex interactions among genetic predisposition, hormonal fluctuations, UV exposure, oxidative stress, inflammation, and photoaging. Its psychosocial impact is substantial, especially among women with darker skin types, and treatment remains challenging due to ...
Ting Liao, Rui Luo, Ying Deng, Hongqiu Yang, Yu Du   +4 more
wiley   +1 more source

Imatinib-induced hyperpigmentation

JAAD Case Reports
Garraway, Caroline, Yang, Kevin, Kantamneni, Kavita, Kissel, Rebecca, Pavlidakey, Peter G.   +4 more
openaire   +2 more sources

Linear Hyperpigmentation in a Boy with Vitiligo

Avita Dhiman, Payal Chauhan, Manju Daroach   +2 more
openalex   +1 more source

Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have gained rapid popularity for both medical and consumer‐directed weight loss. This growth has been accompanied by increased public discussion regarding facial aesthetic changes, commonly referred to as “Ozempic face,” characterized by volume depletion and cutaneous laxity ...
Alec D. McCarthy, Kay Durairaj, Jacob Linneman‐Heath, Dusan Sajic, Mara Dacso, Alan Durkin   +5 more
wiley   +1 more source

Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports. [PDF]

Clin Cosmet Investig Dermatol
Zhang W, Mao D, Zhou C, Wen G.
europepmc   +1 more source

Successful Re‐Pigmentation of IPL‐Induced Hypopigmentation Using Topical Bimatoprost

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
Ivaylo Ivanov, Tatjana Pavicic
wiley   +1 more source

Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP‐1/GIP Agonists), Surgical, or Behavioral Interventions

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background GLP‐1 receptor agonists (GLP‐1) and dual GLP‐1/gastric inhibitory polypeptide (GIP) agonists emerged in recent years to promote weight loss. By reducing subcutaneous fat, collagen, and overall structural support of the skin, rapid weight loss can lead to visual face aging.
Nhi Nguyen, Alejandra Aguilar, Nasima Afzal, Andy Lee, Wardah Akram, Minh N. Duong, Raja K. Sivamani   +6 more
wiley   +1 more source